OFIX Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Orthofix Medical Inc (OFIX) is not a strong buy for a beginner long-term investor at this time. While the company is undergoing enterprise-wide changes and improving profitability, its financial performance shows declining net income and EPS, and analysts indicate that top-line acceleration may not be visible until late 2026. The technical indicators and options data do not suggest a compelling entry point, and there are no significant positive catalysts or recent influential trades to support a buy decision.
The MACD is positive and expanding, which is a bullish signal, but the RSI is neutral at 69.456, and moving averages are converging, indicating no clear trend. The stock is trading near its first resistance level (R1: 13.819), suggesting limited immediate upside potential.
Analysts are positive on ongoing efforts to reshape the investment story.
No significant hedge fund, insider, or congress trading activity has been reported. There is no recent news or event-driven catalyst.
In Q3 2025, revenue increased by 4.59% YoY to $205.63M, but net income dropped by 16.77% to -$22.8M, and EPS fell by 19.72% to -0.57. Gross margin improved to 70.71%, up 6.52% YoY.
TD Cowen initiated coverage with a Hold rating and a $14 price target, citing positive changes in profitability and cash flow but expressing concerns about the lack of visible top-line acceleration until late 2026.
